The International Council for Harmonisation has finalized a high-level document to complement and further clarify its E11 guideline on the clinical investigation of medicinal products in the pediatric population.
The new document, E11(R1), has been issued as an addendum to the guideline, which has been in place...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?